Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma.

Takata A, Takiguchi S, Okada K, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Mori M, Doki Y.

Anticancer Res. 2014 May;34(5):2427-32.

PMID:
24778055
2.

Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.

Hui MK, Chan KW, Luk JM, Lee NP, Chung Y, Cheung LC, Srivastava G, Tsao SW, Tang JC, Law S.

World J Surg. 2012 Jan;36(1):90-7. doi: 10.1007/s00268-011-1302-5.

3.

Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.

Makino T, Yamasaki M, Takemasa I, Takeno A, Nakamura Y, Miyata H, Takiguchi S, Fujiwara Y, Matsuura N, Mori M, Doki Y.

Ann Surg Oncol. 2009 Jul;16(7):2058-64. doi: 10.1245/s10434-009-0476-7. Epub 2009 Apr 30.

PMID:
19408050
4.

Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.

Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Mori M, Doki Y.

Oncol Rep. 2012 Apr;27(4):940-6. doi: 10.3892/or.2011.1607. Epub 2011 Dec 22.

5.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
6.

High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.

Hao CL, Li Y, Yang HX, Luo RZ, Zhang Y, Zhang MF, Cheng YF, Wang X.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4213-21. eCollection 2014.

7.

Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Li LY, Li EM, Wu ZY, Cao HH, Shen JH, Xu XE, Chen B, Wu JY, Xu LY.

Int J Clin Exp Pathol. 2014 May 15;7(6):3132-40. eCollection 2014.

8.

Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

Zhang J, Yang Y, Chen L, Zheng D, Ma J.

Acta Histochem. 2014 Apr;116(3):435-9. doi: 10.1016/j.acthis.2013.09.011. Epub 2013 Oct 28.

PMID:
24176776
9.

The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

Kim SH, Kim JH, Yu EJ, Lee KW, Park CK.

Histol Histopathol. 2012 Jan;27(1):49-58.

PMID:
22127596
10.

The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.

Zhang JY, Bai CY, Bai YQ, Zhang JY, Wu ZY, Wang SH, Xu XE, Wu JY, Zhu Y, Rui Y, Li EM, Xu LY.

Hum Pathol. 2014 Oct;45(10):2014-22. doi: 10.1016/j.humpath.2014.05.014. Epub 2014 Jun 12.

PMID:
25090917
11.

[Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].

Liu HB, Yang QC, Shen Y, Zhu Y, Zhang XJ, Chen H.

Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):361-5. doi: 10.3760/cma.j.issn.0253-3766.2013.05.009. Chinese.

PMID:
24054013
12.

Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.

Yang DK, Son CH, Lee SK, Choi PJ, Lee KE, Roh MS.

Hum Pathol. 2009 Apr;40(4):464-70. doi: 10.1016/j.humpath.2008.10.001. Epub 2009 Jan 3.

PMID:
19121844
13.

Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.

Shiozaki A, Nakashima S, Ichikawa D, Fujiwara H, Konishi H, Komatsu S, Kubota T, Okamoto K, Iitaka D, Shimizu H, Nako Y, Takemoto K, Kishimoto M, Otsuji E.

Anticancer Res. 2013 Oct;33(10):4329-35.

PMID:
24123000
14.

Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.

Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H.

J Surg Oncol. 2005 May 1;90(2):89-94.

PMID:
15844180
15.

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.

Luo KJ, Wen J, Xie X, Fu JH, Luo RZ, Wu QL, Hu Y.

Ann Thorac Surg. 2012 May;93(5):1682-8. doi: 10.1016/j.athoracsur.2012.01.102. Epub 2012 Apr 4.

PMID:
22480390
16.

Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.

Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L, Li SQ.

Med Oncol. 2012 Mar;29(1):151-60. doi: 10.1007/s12032-010-9816-5. Epub 2011 Jan 23.

PMID:
21259057
17.

High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.

Yeh CJ, Chuang WY, Chao YK, Liu YH, Chang YS, Kuo SY, Tseng CK, Chang HK, Hsueh C.

Virchows Arch. 2011 Feb;458(2):171-8. doi: 10.1007/s00428-010-0994-5. Epub 2010 Nov 3.

PMID:
21046149
18.

[Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].

Zhang Y, Liu YP, Du K, Wang H, Wang XL.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):594-8. Chinese.

PMID:
22325219
19.

Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Zhang X, He C, He C, Chen B, Liu Y, Kong M, Wang C, Lin L, Dong Y, Sheng H.

Pathol Res Pract. 2013 Aug;209(8):510-5. doi: 10.1016/j.prp.2013.06.005. Epub 2013 Jun 28.

PMID:
23880164
20.

Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.

Zhang L, Ye SB, Li ZL, Ma G, Chen SP, He J, Liu WL, Xie D, Zeng YX, Li J.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3887-97. eCollection 2014.

Items per page

Supplemental Content

Write to the Help Desk